CoChat
Sign Up
Cited by 162

Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells

Almeida, Maria I., Nicoloso, Milena S., Zeng, Lizhi, Ivan, Cristina, Spizzo, Riccardo, Gafà, Roberta, Xiao, Lianchun, Zhang, Xinna +7 more·2012·Gastroenterology
DOI 10.1053/j.gastro.2011.12.047PMC PMC3321100
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2011.12.047

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. [1]Jemal A Bray F Center MM Global cancer statistics CA Cancer J Clin 2011 61 2 69 90 21296855
  2. [2]Jemal A Siegel R Xu J Cancer statistics, 2010 CA Cancer J Clin 2010 60 5 277 300 20610543
  3. [3]Calin GA Dumitru CD Shimizu M Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 2002 99 24 15524 9 12434020 PMC137750
  4. [4]Almeida MI Reis RM Calin GA MicroRNA history: Discovery, recent applications, and next frontiers Mutat Res 2011 Epub ahead of print 21458467
  5. [5]Croce CM Causes and consequences of microRNA dysregulation in cancer Nat Rev Genet 2009 10 10 704 714 19763153 PMC3467096
  6. [6]Wu WK Law PT Lee CW MicroRNA in colorectal cancer: from benchtop to bedside Carcinogenesis 2011 32 3 247 253 21081475
  7. [7]Lea MA Recently identified and potential targets for colon cancer treatment Future Oncol 2010 6 6 993 1002 20528236
  8. [8]Griffiths-Jones S Grocock RJ van Dongen S miRBase: microRNA sequences, targets and gene nomenclature Nucleic Acids Res 2006 34 database D140 144 16381832 PMC1347474
  9. [10]Lefever S Hellemans J Pattyn F RDML: structured language and reporting guidelines for real-time quantitative PCR data Nucleic Acids Res 2009 37 7 2065 9 19223324 PMC2673419
  10. [11]Schmittgen TD Livak KJ Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 2008 3 6 1101 8 18546601
  11. [12]Pfaffl MW A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 2001 29 9 e45 11328886 PMC55695
  12. [13]Galluzzi L Aaronson SA Abrams J Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes Cell Death Differ 2009 16 8 1093 1107 19373242 PMC2757140
  13. [14]Chaitanya GV Steven AJ Babu PP PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration Cell Commun Signal 2010 8 31 21176168 PMC3022541
  14. [15]Girardot M Pecquet C Boukour S miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets Blood 2010 116 3 437 445 20445018
  15. [16]Gottardo F Liu CG Ferracin M Micro-RNA profiling in kidney and bladder cancers Urol Oncol 2007 25 5 387 392 17826655
  16. [17]Malzkorn B Wolter M Liesenberg F Identification and functional characterization of microRNAs involved in the malignant progression of gliomas Brain Pathol 2010 20 3 539 550 19775293 PMC8094849
  17. [18]Spizzo R Nicoloso MS Croce CM SnapShot: MicroRNAs in cancer Cell 2009 137 3 586 586.e1 19410551
  18. [19]Jiang L Huang Q Zhang S Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells BMC Cancer 2010 10 318 20569443 PMC2903529
  19. [20]Volinia S Galasso M Costinean S Reprogramming of miRNA networks in cancer and leukemia Genome Res 2010 20 5 589 99 20439436 PMC2860161
  20. [21]López JA Alvarez-Salas LM Differential effects of miR-34c-3p and miR-34c-5p on SiHa cells proliferation apoptosis, migration and invasion Biochem Biophys Res Commun 2011 409 3 513 519 21600876
  21. [22]Yang M Yao Y Eades G MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism Breast Cancer Res Treat 2011 Epub ahead of print PMC3752913 21638050
  22. [23]Arber N Hibshoosh H Moss SF Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis Gastroenterology 1996 110 3 669 674 8608874
  23. [24]Diehl JA Cycling to cancer with cyclin D1 Cancer Biol Ther 2002 1 3 226 231 12432268
  24. [25]Fu M Wang C Li Z Mini review: Cyclin D1: normal and abnormal functions Endocrinology 2004 145 12 5439 5447 15331580
  25. [26]Arber N Doki Y Han EK Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells Cancer Res 1997 57 8 1569 1574 9108461
  26. [27]Kanai M Hamada J Takada M Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas Oncol Rep 2010 23 3 843 851 20127028
  27. [28]Palakurthy RK Wajapeyee N Santra MK Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression Mol Cell 2009 36 2 219 230 19854132 PMC2776651
  28. [29]Lee S Hwang KS Lee HJ Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia Lab Invest 2004 84 7 884 893 15122305
  29. [30]Björnsson JM Larsson N Brun AC Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4 Mol Cell Biol 2003 23 11 3872 3883 12748289 PMC155209
  30. [31]Krosl J Baban S Krosl G Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1 Oncogene 1998 16 26 3403 3412 9692548
  31. [32]Lee JH Marshall JC Steeg PS Altered gene and protein expression by Nm23-H1 in metastasis suppression Mol Cell Biochem 2009 329 1-2 141 148 19415462 PMC3514412
  32. [33]Steeg PS Bevilacqua G Kopper L Evidence for a novel gene associated with low tumor metastatic potential J Natl Cancer Inst 1988 80 3 200 204 3346912
  33. [34]Steeg PS Bevilacqua G Pozzatti R Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis Cancer Res 1988 48 22 6550 6554 2460224
  34. [35]Marshall JC Collins J Marino N The Nm23-H1 metastasis suppressor as a translational target Eur J Cancer 2010 46 7 1278 1282 20304626 PMC2858387
  35. [36]Boissan M De Wever O Lizarraga F Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells Cancer Res 2010 70 19 7710 7722 20841469
  36. [37]Suzuki E Ota T Tsukuda K nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation Int J Cancer 2004 108 2 207 211 14639604

Cited by

Sorted by citations

Authors
Almeida, M. I., Nicoloso, M. S., Zeng, L., Ivan, C., Spizzo, R., Gafà, R., Xiao, L., Zhang, X., Vannini, I., Fanini, F., Fabbri, M., Lanza, G., Reis, R. M., Zweidler–McKay, P. A., & Calin, G. A.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2012-04
Volume
142
Issue
4
Pages
886-896.e9
ISSN
0016-5085
DOI
10.1053/j.gastro.2011.12.047
PMC
PMC3321100
Cited by
162
References
2
Language
en
Licence
Funders
  • National Institutes of Health (CA135444)
  • U.S. Department of Defense
  • National Cancer Institute (CA16672)
  • Pancreatic Cancer Action Network

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review